Trial Profile
Zoledronic Acid (Zometa) for the Management of Tumor-Induced Hypercalcemia (TIH) and Malignant Bone Pain (MBP) in the Community: A Feasibility Study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Jul 2022
Price :
$35
*
At a glance
- Drugs Zoledronic acid (Primary)
- Indications Cancer pain; Malignant hypercalcaemia; Musculoskeletal pain
- Focus Therapeutic Use